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ABSTRACT 17 
Bacteriocins from lactic acid bacteria (LAB) are of increasing interest in recent years due to 18 
their potential as natural preservatives against food and beverage spoilage microorganisms. In 19 
a screening study for LAB, we isolated a strain, Lactobacillus plantarum NI326, from olives 20 
with activity against a strain belonging to the beverage-spoilage bacterium Alicyclobacillus 21 
acidoterrestris spp. Genome sequencing of the strain enabled the identification of a gene 22 
cluster encoding a putative circular bacteriocin and proteins involved in its modification, 23 
transport and immunity. This novel bacteriocin, named plantaricyclin A (PlcA), was grouped 24 
into the circular bacteriocin subgroup II due to its high degree of similarity with other 25 
gassericin A-like bacteriocins. Purification of the supernatant of Lb. plantarum NI326 resulted 26 
in an active peptide with a molecular mass of 5,570 Da, corresponding to that predicted from 27 
the (processed) PlcA amino acid sequence. The Plc gene cluster was subsequently cloned and 28 
expressed in L. lactis NZ9000, resulting in the production of an active 5,570 Da bacteriocin in 29 
the supernatant. PlcA is produced as a 91-amino acid precursor with a 33 amino acid leader 30 
peptide. This leader peptide is predicted to be removed, after which the N- and C-termini are 31 
joined via a covalent linkage to form the mature 58 amino acid circular bacteriocin PlcA. This 32 
is the first report of a characterized circular bacteriocin produced by Lb. plantarum and the 33 
inhibition displayed against A. acidoterrestris sp1 highlights the potential use of this 34 
bacteriocin as a preservative in food and beverages. 35 
 36 
IMPORTANCE 37 
In this work we describe the purification and characterization of a new antimicrobial peptide, 38 
termed Plantaricyclin A (PlcA), produced by a Lactobacillus plantarum strain isolated from 39 
olives. This peptide has a circular structure, and all the genes involved in its production, 40 
circularization and secretion have been identified. PlcA shows antimicrobial activity against 41 
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different strains, including Alicyclobacillus acidoterrestris, a common beverage spoilage 42 
bacteria causing important economic losses in the beverage industry every year. PlcA is the 43 
first circular antimicrobial peptide described from Lactobacillus plantarum. 44 
  45 
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INTRODUCTION 46 
Bacteriocins are ribosomally synthesized antimicrobial peptides produced by bacteria to 47 
inhibit the growth of other, often closely related, strains. Bacteriocin production is a common 48 
feature among food-grade lactic acid bacteria (LAB), and bacteriocins have, for this reason, 49 
attracted considerable interest for their potential use as natural and non-toxic food 50 
preservatives (1, 2). Some of these peptides have demonstrated greater efficacy than 51 
conventional antibiotics against numerous pathogenic and drug-resistant bacteria, while 52 
displaying no toxicity toward eukaryotic cells (3). For this reason, bacteriocins may also be 53 
useful in human and veterinary applications as a powerful weapon in the ongoing battle 54 
against antibiotic resistance, and for the treatment of local and systemic bacterial infections (3-55 
5).  56 
 57 
A recent classification of bacteriocins of LAB established three main groups of these peptides 58 
(6). Class I and class II are represented by heat-stable bacteriocins (<10 kDa), while class III 59 
includes the thermo-labile bacteriocins (>10 kDa). Class I encompasses bacteriocins that 60 
undergo enzymatic modification during biosynthesis, and this class is further subdivided into 61 
six subclasses: lanthiopeptides, circular bacteriocins, sactibiotics, linear azol(in)e-containing 62 
peptides (LAPs), glycocins and lasso peptides. Class II bacteriocins include unmodified 63 
bacteriocins, and this group is subdivided into four subclasses: pediocin-like, two-peptide, 64 
leaderless and non-pediocin-like single-peptide bacteriocins. Class III includes (heat-sensitive) 65 
unmodified bacteriocins larger than 10 kDa with a bacteriolytic or non-lytic mechanism of 66 
action. This group can be further subdivided into two classes: the bacteriolysins and the non-67 
lytic bacteriocins.  68 
 69 
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Class Ib or circular bacteriocins constitute a unique family of active proteins in which the N- 70 
and C-terminal ends are covalently linked to form a circular backbone. This additional bond is 71 
thought to enhance the thermodynamic stability and structural integrity of the peptide and 72 
consequently improve its biological activity (7-9). To date, only a small number of circular 73 
bacteriocins have been described. These can be subdivided in two major groups according to 74 
their physicochemical characteristics and level of sequence identity (9). Subgroup I 75 
encompasses circular bacteriocins with a high content of positively charged amino acids and a 76 
high isoelectric point (pI of ~10). This includes the most studied circular bacteriocin, enterocin 77 
AS-48 (10), together with other bacteriocins such as carnocyclin A (11), circularin A (12), 78 
lactocyclin Q (13), and garvicin ML (14). Subgroup II circular bacteriocins include 79 
bacteriocins with a smaller number of positively charged amino acid residues and a medium to 80 
low isoelectric point (pI between ~ 4 and 7). Currently this group comprises just three 81 
members, gassericin A (15), butyrivibriocin AR10 (16) and acidocin B (17). However there  is 82 
an absence of consensus regarding the classification of circular bacteriocins, as some authors 83 
consider that they should be grouped as Class II bacteriocins, instead of Class I (1). 84 
 85 
In this study we screened 50 colonies, isolated from olives, for their potential to inhibit growth 86 
of the beverage-spoilage strain Alicyclobacillus acidoterrestris sp1. We report the purification 87 
and genetic characterization of a novel circular gassericin A-like bacteriocin, termed 88 
plantaricyclin A produced by Lactobacillus plantarum NI326, with antimicrobial activity 89 
against various microorganisms including A. acidoterrestris sp1.  90 
 91 
  92 
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MATERIALS AND METHODS 93 
 94 
Cultures and growth conditions 95 
The strains used in this study are summarized in Table 1. All Lactobacillus, Pediococcus and 96 
Leuconostoc strains were grown in MRS (Oxoid, Hampshire, U.K.) at 30 °C, A. 97 
acidoterrestris sp1 was grown in BAT broth (Pronadisa, Spain) at 45°C, while some of the 98 
other indicator strains were grown in LB broth (1 % Peptone, 1 % NaCl, 0.5 % Yeast extract) 99 
at 37 °C (Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae), BHI broth 100 
(Oxoid) at 37 °C (Staphylococcus aureus, Listeria monocytogenes, Listeria innocua and 101 
Bacillus cereus), TSB broth (Oxoid) at 37°C (Streptococcus uberis and Streptococcus 102 
dysgalactiae) and M17 broth (Oxoid) supplemented with 0.5 % glucose (Sigma-Aldrich, 103 
USA) at 30 °C (Lactococcus lactis) or at 37 °C (Enterococcus faecium). Chloramphenicol 104 
(Sigma-Aldrich) was added at 5 µg/ml where reqired. All microorganisms were grown under 105 
aerobic conditions. All strains were stored at -80 °C in their respective media with 20 % 106 
glycerol until required. 107 
 108 
Isolation of LAB strains from olives 109 
Over 50 isolates were isolated from olives as previously described (18). Briefly, 5 g olives 110 
were homogenised with 45 ml Ringers solution using a stomacher at 300 bpm for 1 min 111 
(Stomacher circular 400, Seward, UK). Homogenate was serially diluted in Ringers solution, 112 
and 100 µl of each dilution plated on MRS agar (Oxoid) plates supplemented with 100 µg/mL 113 
cycloheximide (Sigma) to suppress fungal growth. Plates were then incubated at 30 °C 114 
anaerobically for 2 days. Colonies obtained were handpicked and inoculated into 250 µl 115 
aliquots of MRS broth in 96 well plates. Cultures were grown anaerobically overnight at 30 °C 116 
and stored at -80 °C with 20 % glycerol for further analysis. 117 
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 118 
Isolation of anti-A. acidoterrestris sp1 bacteriocin-producing LAB 119 
LABs exerting antimicrobial activity were identified using the spot-on-lawn method (18). 120 
Briefly, 5 µl aliquots of LAB cultures were spotted onto MRS agar plates and grown at 30 °C 121 
anaerobically for 48 h. Plates were then overlaid with 5 mL of MRS soft agar (MRS broth 122 
supplemented with 0.8 % bacteriological agar) seeded with 10
5
 – 106 CFU/mL of an overnight 123 
culture of L. lactis HP. Plates were incubated at 30 °C for 48 h after which zones of inhibition 124 
surrounding the LAB colony were measured.  125 
The LAB isolate showing inhibition against L. lactis HP was further cultured in 10 ml MRS 126 
broth and grown at 30 °C overnight. Cell-free culture supernatant (CFS) was obtained by 127 
centrifugation of the culture at 12,000 g, 4 °C for 10 min and filtered through 0.2 μm pore-size 128 
filters (Whatman Int. Ltd., Maidstone, UK). The activity of the CFS against A. acidoterrestris 129 
sp1 was analysed using an agar diffusion test (ADT) (19). Briefly, 100 μl aliquots of CFS were 130 
placed in wells (6-mm diameter) bored in cooled Alicyclobacillus agar (Pronadisa) plates (30 131 
ml) previously seeded (10
5
 CFU/ml) with A. acidoterrestris sp1. Plates were incubated at 50 132 
°C to allow growth of the target organism and checked for zones of inhibition after 24-48 h.  133 
 134 
Identification of LAB isolates  135 
Individual colonies were used as templates for PCR. The primers Luc-F (5’ CTT GTT ACG 136 
ACT TCA CCC 3’) and Luc-R (5’ TGC CTA ATA CAT GCA AGT 3’) (Eurofins MWG, 137 
Ebersberg, Germany) were used to amplify a variable region of the 16S rRNA gene (20). The 138 
following conditions were used for the PCR reactions: 95 °C for 60 s, 53 °C for 60 s, and 72 139 
°C for 95 s, for 30 cycles. The DNA from individually purified amplicons was subjected to 140 
Sanger sequencing (Eurofins MWG) and the corresponding species identity was obtained by 141 
comparative sequence analysis (BLASTN) against available sequence data in the National 142 
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Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov/ 143 
BLAST). 144 
 145 
Lactobacillus. plantarum NI326 genome sequencing, genome annotation and bacteriocin 146 
screening 147 
The genome of Lb. plantarum NI326 was sequenced using a combined Roche GS-FLX 148 
Titanium and Illumina HiSeq 2000 approach (GATC Biotech, Konstanz, Germany), to a final 149 
coverage of ~490-fold. Sequences obtained were first quality checked using IlluQC.pl from 150 
the NGS QC Toolkit (v2.3) (http://www.nipgr.res.in/ngsqctoolkit.html) (21) and assembled 151 
with AbySS (v1.9.0) (22). 152 
Following sequence assembly, the generated contigs were employed to perform Open Reading 153 
Frame (ORF) prediction with Prodigal v2.5 prediction software (http://prodigal.ornl.gov), 154 
supported by BLASTX v2.2.26 alignments (23). ORFs were automatically annotated using 155 
BLASTP v2.2.26 (23) analysis against the non-redundant protein databases curated by the 156 
NCBI Database. Following automatic annotation, ORFs were manually curated using Artemis 157 
v16 genome browser and annotation tool (http://www.sanger.ac.uk/science/tools/artemis). The 158 
software tool was used to inspect and validate ORF results, to adjust start codons where 159 
necessary, and to aid in the identification of pseudogenes. The resulting ORF annotations were 160 
further refined, where required, using alternative databases; Pfam (24) and Uniprot/EMBL 161 
(http://www.uniprot.org/). Transfer tRNA was predicted using tRNA-scan-SE v1.4 (25). The 162 
whole genome was analysed with the web-based bacteriocin genome mining tool BAGEL3 163 
(http://bagel.molgenrug.nl/) (26) to search for known and/or potential novel bacteriocins.  164 
 165 
Accession numbers 166 
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The GenBank accession number provided for the nucleotide sequence reported in this study is 167 
NDXC00000000.   168 
 169 
Molecular cloning of plc gene cluster, plcD and plcI into pNZ8048 and transformation in 170 
L. lactis NZ9000  171 
The primers, PCR fragments and plasmids used in this study are listed in Table 2. All primers 172 
were ordered from Eurofins MWG. Plasmid derivatives were constructed as follows: primers 173 
Plc-F/Plc-R were used for PCR-amplification of a 3,172-bp fragment from total genomic DNA 174 
of Lb. plantarum NI326, which encompassed the entire plc gene cluster including its 175 
promoter(s). Using this plc gene cluster fragment as template and the primer pairs NcoI-176 
Plc/XbaI-Plc, NcoI-PlcD/XbaI-PlcD, NcoI-PlcI/XbaI-PlcI and NcoI-PlcD/XbaI-PlcI, 177 
fragments encompassing plcADITEB, plcD, plcI and plcDI, respectively, were amplified 178 
(Table 3). Such fragments were digested with NcoI and XbaI and ligated into pNZ8048, 179 
digested with the same enzymes. The ligation mixtures were used to transform L. lactis 180 
NZ9000 competent cells as previously described (27). The plasmid derivatives pNZPlc, 181 
pNZPlcD, pNZPlcI and pNZPlcDI, were checked by colony-PCR and sequencing of the 182 
inserts using primers PNZ-F/PNZ-R. 183 
 184 
Purification and MALDI TOF mass spectrometry analysis of PlcA 185 
PlcA was purified from Lb. plantarum NI326 and L. lactis NZ9000 transformed with pNZPlc, 186 
as described previously (28) with  modifications. Briefly, a 1 L CFS of Lb. plantarum NI326 187 
was obtained as previously described. Recombinant L. lactis NZ9000 – pNZPlc was induced 188 
for the production of PlcA at an optical density at 600 nm (OD600) of 0.5, using nisin A 189 
(Nisaplin, Dupont, USA) at a final concentration of 10 ng/ml. The induced culture was grown 190 
at 32 °C for 3 h. CFS was obtained by centrifugation of the culture at 12,000 × g at 4 °C for 10 191 
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min. Activity of the CFS from either strain against A. acidoterrestris sp1 was confirmed on an 192 
ADT as previously described. CFS was applied to a 10g (60 ml) Varian C-18 Bond Elution 193 
Column (Varian, Harbor City, CA) pre-equilibrated with methanol and water. The column was 194 
washed with 20 % ethanol and the inhibitory activity was eluted in 100 mls of 70 % 2-195 
propanol 0.1 % TFA. 15 ml aliquots were concentrated to 2 ml through the removal of 2-196 
propanol by rotary evaporation (Buchi). Samples were then applied to a semi preparative 197 
Vydac C4 Mass Spec (10 x 250 mm, 300Å, 5µ) RP-HPLC column (Grace, Columbia, USA) 198 
running an acetonitrile and propan-2-ol gradient described as follows: 5-55 % buffer B and 0-5 199 
% buffer C over 25 minutes followed by and 55-19 % buffer B and 5-65 % buffer C over 60 200 
minutes, 19-5 % buffer B and 65-95 % buffer C over 5 minutes where buffer A is Milli Q 201 
water containing 0.1 % TFA, buffer B is 90 % acetonitrile 0.1 % TFA and buffer C is 90 % 202 
propan-2-ol 0.1 % TFA.  Eluent was monitored at 214 nm and fractions were collected at 1 203 
minute intervals. Fractions were assayed on Lactobacillus bulgaricus indicator plates and 204 
active fractions assayed for the antimicrobial mass of interest using MALDI TOF mass 205 
spectrometry (MALDI TOF MS).  MALDI TOF MS was performed with an Axima TOF
2
 206 
MALDI TOF mass spectrometer (Shimadzu Biotech, Manchester, UK) as described by Field 207 
et al (28).  208 
 209 
Analysis of Immunity against PlcA 210 
The immunity of wild type L. lactis NZ9000 and recombinant strains L. lactis NZ9000 – 211 
pNZPlcD, L. lactis NZ9000 – pNZPlcI and L. lactis NZ9000 – pNZPlcDI was tested against 212 
CFS from Lb. plantarum NI326 on an ADT assay as above described. The indicator strains 213 
were seeded in GM17 – 0.8 % agar with and without 10 ng/ml Nisin A. The area of zones of 214 
inhibition was measured after 24 hours growth at 30 °C. The absence of a zone indicates that 215 
the strain is immune to PlcA. 216 
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 217 
Sensitivity of PlcA to heat, pH and proteolytic enzymes 218 
Aliquots of  PlcA-containing fraction obtained following Reversed Phase HPLC were 219 
subjected to the following treatments: (i) 20-fold (v/v) dilution with 30 % 2-propanol 220 
containing 0.1 % TFA and heating at 80 ºC and 100 ºC for 30 min and at 121 ºC for 15 min to 221 
determine the stability of PlcA to heat; (ii) 20-fold (v/v) dilution in 10 mM Tris buffer 222 
followed by pH adjustment at 2, 3, 4, 5, 6, 7, 8, 9 and 10 with 1 M HCl or 1 M NaOH to 223 
evaluate the effect of pH on bacteriocin activity; and (iii) dilution as in (ii) followed by the 224 
addition of α-chymotrypsin (Sigma), pepsin (Sigma), pronase (Sigma) and proteinase K 225 
(Sigma) at pH 7.0. Each enzyme was added to a final concentration of 1 mg/ml, to determine 226 
PlcA sensitivity to proteolytic enzymes. After each treatment, the residual antimicrobial 227 
activity of PlcA was determined by the agar diffusion test (ADT) with A. acidoterrestris sp1 as 228 
the indicator microorganism. 229 
 230 
Antimicrobial spectrum of PlcA 231 
Aliquots of PlcA were used to test its antimicrobial activity against various indicators (Table 232 
1) using an ADT assay as described above. 233 
 234 
  235 
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RESULTS AND DISCUSSION 236 
 237 
Alicyclobacillus acidoterrestris is considered to be one of the species with the highest food 238 
spoilage impact worldwide (29). They are thermo-acidophilic spore-forming bacteria with a 239 
strong spoiling potential especially in low pH juices. The presence of A. acidoterrestris in 240 
juices is difficult to detect visually, but its presence is associated with an unpleasant odour 241 
caused by the production of guaiacol and other halophenols by the strain. Bacteriocins, such as 242 
the lantibiotic nisin A or the circular bacteriocin enterocin AS-48, have shown some promising 243 
results as strategies to inhibit growth of A. acidoterrestris in juices (30, 31).  244 
 245 
Isolation and identification of Lactobacillus plantarum NI326.  246 
In this study we screened a number of isolates of LAB from olives with the aim of selecting 247 
those showing antimicrobial activity against A. acidoterrestris sp1. 50 potential LAB isolates 248 
were obtained from the olive homogenate plated on MRS plates. Single colonies were streaked 249 
onto fresh MRS plates and overlaid with L. lactis HP. Only one out of the 50 tested colonies 250 
exhibited a zone of inhibition against the indicator strain. A CFS of this strain produced an 251 
inhibitory zone against A. acidoterrestris sp1 on an ADT, confirming that this isolate produces 252 
an extracellular antimicrobial compound against A. acidoterrestris sp1. This colony was 253 
identified as Lb. plantarum by 16S rDNA sequencing and designated Lb. plantarum NI326. 254 
No zone of inhibition was apparent when the CFS was first treated with proteinase K 255 
confirming the proteinaceous nature of the antimicrobial compound (data not shown).  256 
 257 
Genome sequence analysis and annotation bacteriocin encoding gene cluster of Lb. 258 
plantarum NI326.  259 
To find potential bacteriocin-encoding gene clusters, the entire genome of Lb. plantarum 260 
NI326 was sequenced generating 84 contigs following sequence assembly. In silico analysis of 261 
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the 84 contigs with BAGEL3 detected a potential bacteriocin gene cluster predicted to encod a 262 
peptide with a 43-AA putative conserved domain corresponding to the class Ib-subgroup II 263 
gassericin A-like circular bacteriocins. This putative peptide, designated here as plantaricyclin 264 
A (PlcA), exhibits 67 % similarity to the circular bacteriocin gassericin A. An alignment of 265 
this peptide with the other members of the gassericin A-like circular bacteriocin group: 266 
gassericin A (GaaA), acidocin B (AciB) and butyrivibriocin AR10 (BviA), revealed a high 267 
degree of similarity with PlcA facilitated the prediction of the potential cleavage site of the 268 
signal peptide from the mature peptide to be between amino acids N33 and I34 (Figure 1). 269 
Both GaaA and AciB are synthesized as 91 AA pre-peptides with 33 AA leader peptides that 270 
are cleaved off, followed by a covalent linkage between the N- and C-terminus, to form the 271 
mature 58 amino acid circular bacteriocin. In previous studies, sequence alignments between 272 
characterized and hypothetical subgroup II circular bacteriocins has revealed the presence of a 273 
fully conserved asparaginyl cleavage site (17), which is also present in PlcA.  274 
 275 
The function of these leader peptides and mechanism through which peptide circularization 276 
occurs is still unclear. One of the biggest challenges in the field of circular proteins is finding 277 
out how their ends are stitched together from their linear precursors (32). Identification of the 278 
mechanism involved has to potential to facilitate the creation of new, highly stable 279 
antimicrobial agents for use in food, veterinary and medical applications (11). PlcA has a 280 
predicted mass of 5,588 Da and represents a new bacteriocin within the Class Ib Subgroup II 281 
and the first (predicted) circular bacteriocin isolated from Lb. plantarum. 282 
 283 
Analysis of the PlcA gene cluster revealed the presence of seven ORFs downstream of the 284 
PlcA-encoding gene (plcA), with sequence and organisational similarity to those found in the 285 
gene clusters responsible for GaaA and AciB production (Figure 2). Accordingly, plcA is 286 
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followed by plcD, which encodes a putative 157 AA membrane associated protein with a 287 
DUF95 conserved domain. Recent research suggests that DUF95 proteins play a dual role in 288 
the biosynthesis of circular peptides, as an immunity-associated transporter protein and as a 289 
secretion-aiding agent (33). ORF plcI is immediately downstream of plcD, and encodes a 54 290 
AA protein with a hypothetical function as an immunity protein. Kawai et al (34) showed that 291 
heterologous expression of GaaI in Lactococcus lactis confers a 7-fold higher resistance to 292 
gassericin A compared to a control strain. 293 
 294 
The next two genes of the cluster (plcE and plcT) encode proteins of 227 AA and 214 AA, 295 
respectively. Both have conserved ATP-binding domains linked to proteins of the ABC 296 
transporter family and based on homology to their equivalents from GaaA and AciB clusters, 297 
they are most likely involved in the secretion of PlcA. The downstream plcB and plcC genes 298 
are located in positions that are different from their homologs in the clusters for GaaA and 299 
AciB production (Figure 2). The function of the proteins coded by these two genes is still 300 
unknown, but their presence in all of the clusters from circular bacteriocins clearly indicates 301 
that they must play an important role (8).  302 
 303 
Heterologous production of PlcA in L. lactis NZ9000 304 
To further confirm that PlcA is responsible for the activity shown by Lb. plantarum NI326, the 305 
entire plc cluster was cloned into the nisin-inducible plasmid pNZ8048 (pNZPlc) and 306 
transformed into L. lactis NZ9000, a naturally non-bacteriocin producing strain. The CFS from 307 
L. lactis pNZPlc exhibited antimicrobial activity against A. acidoterrestris sp1 similar to that 308 
from the wildtype Lb. plantarum NI326 (Figure 3a). The production of PlcA by L. lactis 309 
confirms that the cluster contains all the information necessary for the correct production, 310 
modification and secretion of PlcA. Based on these results and the similarity of the plc cluster 311 
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to those from GaaA and AciB, we can hypothesize that the biosynthetic machinery for all 312 
members of this bacteriocin subgroup is similar.  313 
 314 
Analysis of immunity to PlcA 315 
In order to determine if plcD and/or plcI code immunity proteins for PlcA, the genes were 316 
cloned individually or together in the NisA-inducible vector pNZ8048 and transformed into L. 317 
lactis NZ9000. The recombinant strain L. lactis NZ9000 – pNZPlcDI induced with nisin A 318 
displayed full resistance to PlcA while strains L. lactis NZ9000 – pNZPlcD and L. lactis 319 
NZ9000 – pNZPlcI induced with nisA showed  86 % and 62 % sensitivity against PlcA, 320 
respectively, in comparison to the activity of the bacteriocin against the control strain L. lactis 321 
NZ9000 – pNZ8048 (Figure 3b). Therefore, although both proteins individually appeared to 322 
confer partial immunity to L. lactis NZ9000 against the antimicrobial activity of PlcA, the 323 
recombinant strain was fully protected against the action of PlcA when both proteins were 324 
being produced concomitantly. Similar results have been observed with other circular 325 
bacteriocins such as carnocyclin A, where the production of  the immunity protein (CclI) was 326 
not enough to confer full protection to the producer and only when CclD and CclI were co-327 
produced did the strain show full immunity (35).  328 
 329 
Purification and MALDI TOF analyses of the antimicrobial activity of Lb. plantarum 330 
NI326  331 
The antimicrobial peptide produced by Lb. plantarum NI326 and L. lactis pNZPlc CFS was 332 
purified by Reversed Phase-HPLC and the molecular mass analyzed by MALDI TOF MS. In 333 
both cases a single mass of 5,572 Da was detected in the active fractions (Figure 4). The 18 Da 334 
difference between the molecular mass of PlcA and its theoretical mass calculated from the 335 
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AA sequence corresponds to the loss of a molecule of water that occurs during circularization 336 
of the peptide as reported for other circular bacteriocins (17, 36).  337 
 338 
Sensitivity of plantaricyclin A to heat, pH and proteolytic enzymes.  339 
The antimicrobial activity of partially purified PlcA was the same as the initial antagonistic 340 
activity following exposure to temperatures ranging from 30 ºC to 100 ºC for 10 min, 341 
suggesting the relative stability of the bacteriocin.. No antimicrobial activity was lost when 342 
PlcA was adjusted to pH values 2 to 10. The antimicrobial activity of PlcA was completely 343 
lost when treated with proteinase K and pronase, whereas pepsin, and α-chymotrypsin 344 
treatments resulted in the retention of 100 % and 78 % of the initial antagonistic antimicrobial 345 
activity,  respectively (results not shown). 346 
The resistance of circular bacteriocins to temperature, pH variations and proteolytic enzymes 347 
is mainly due to their three-dimensional conformation. The solution structure of acidocin B 348 
has recently been solved. Accordingly, AciB is composed of four α-helices of similar length 349 
folded to form a compact, globular bundle that allow the formation of a central pore, 350 
resembling the structure of the saposins. The surface of acidocin B and gassericin A is 351 
dominated by hydrophobic and uncharged residues and,  therefore, it is believed that the initial 352 
contact between these circular peptides and the target strains is mediated by hydrophobic 353 
interactions (17).  354 
 355 
Antimicrobial spectrum of plantaricyclin A.  356 
Aliquots of the HPLC purified fractions of PlcA were evaluated for their antimicrobial activity 357 
and inhibitory spectrum against different indicator microorganisms. Of these only A. 358 
acidoterrestris sp1, Lb. bulgaricus UCC, Pediococcus inopinatus 1011 and all tested 359 
lactococcal strains were inhibited by the bacteriocin produced by Lb. plantarum NI326 (Table 360 
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1).  In comparison with other circular bacteriocins, PlcA possesses a narrow spectrum of 361 
activity. The low yields obtained during the purification of PlcA may explain the lack of 362 
activity against some of the indicators used.  363 
 364 
In addition to the spectra of inhibition, we observed some other differences between PlcA and 365 
the other members of subgroup II, such as a higher isoelectric point (8.6) and a net charge of 366 
+1. In fact some authors use the pI values and net charges to differentiate between circular 367 
bacteriocins of subgroup I (pI~10 and positively charged) from circular bacteriocins of 368 
subgroup II (pI 4 to 7 and uncharged or slightly negative) (9). According to this classification 369 
system PlcA should be placed in an intermediate position between subgroups I and II. 370 
However, we strongly believe that this peptide should be classified within subgroup II and 371 
propose to modify the classification criteria and broaden the pI range for this subgroup to be 372 
between 4 to ~9. 373 
 374 
The peptide plantaricyclin A is the first circular bacteriocin isolated and characterized from a 375 
Lb. plantarum strain. The high level of antimicrobial activity observed against the food and 376 
beverage spoilage microorganism Alicyclobacillus acidoterrestris is of great interest as this 377 
strain represents a significant problem for the food industry. The use of bacteriocins, such as 378 
nisin A and enterocin AS-48, as preservatives in low pH beverages and juices has shown some 379 
promising results to control the growth of A. acidoterrestris (37). The circular nature of PlcA 380 
makes it especially interesting for industrial applications as this peptide could survive and 381 
retain most of the activity under changing conditions (temperature and pH, for example) 382 
during food/beverage manufacture. Moreover, the narrow spectrum of activity from PlcA can 383 
be considered as an advantage specially in fermented beverages. In comparison to other broad 384 
spectrum bacteriocins such as nisin A or enterocin AS-48, PlcA could be used to specifically 385 
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target A. acidoterrestris spp while having little or no effect against other desirable 386 
microorganisms present in the beverage.  387 
 388 
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Table 1. Strains used in this study, sources, and activity of PlcA (+: zone of inhibition 545 
observed; - : no zone of inhibition observed). 546 
 547 
Strain Source Activity 
   
Alicyclobacillus acidoterrestris sp1 Coca Cola + 
Lactococcus lactis HP UCC +  
Lactococcus lactis KH UCC + 
Lactococcus lactis MG1363 UCC + 
Lactococcus lactis RT28 UCC + 
Lactococcus lactis NZ9000 UCC + 
Lactobacillus bulgaricus UCC UCC   + 
Lactobacillus plantarum -PARA UCC - 
Lactobacillus plantarum WCFSI UCC - 
Lactobacillus brevis MB124 UCC - 
Lactobacillus brevis SAC12 UCC - 
Lactobacillus brevis L102 UCC - 
Lactobacillus brevis L94 UCC - 
Pediococcus claussenii H5 UCC - 
Pediococcus inopinatus 1011 UCC + 
Enterococcus faecium DPC1146 UCC - 
Listeria innocua UCC UCC - 
Listeria monocytogenes EgDe UCC - 
Listeria monocytogenes 33077 UCC - 
Escherichia coli EC10B UCC - 
Staphylococcus aureus DPC5243 UCC - 
Streptococcus uberis ATCC700407 UCC - 
Streptococcus dysgalactiae GrpC UCC - 
Salmonella typhimurium UTC1lux UCC - 
Klebsiella pneumoniae UCC UCC - 
Bacillus cereus DPC6087 UCC - 
   
 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
 562 
 563 
 564 
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Table 2. Putative proteins derived from the plca operon 
 
 
ORF 
Length 
(amino 
acids) 
Amino acids indentity (%) 
relative to gassericin A gene 
cluster homologs 
Hypothetical function  
Genbank 
accession 
no. 
     plcA  90 56 Plantaricyclin A precursor  
plcD 157 33 Unknown, DUF95 family  
plcI  54 33 Immunity  
plcT 227 45 ATP-binding protein  
plcE 214 37 Membrane transporter  
plcB 173 30 Unknown  
plcC 56 35 Unknown  
 565 
 566 
 567 
 568 
 569 
 570 
 571 
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 574 
 575 
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 577 
 578 
 579 
 580 
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 584 
 585 
 586 
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 590 
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 595 
 596 
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 600 
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 603 
 604 
Table 3. Primers, PCR products and plasmids used in this study. 605 
 606 
Primer Nucleotide sequence (5’ - 3’)a PCR 
fragment 
Plc-F AACGCAAATGTTCCACACGG Plc-Clust 
Plc-R  GGATTGGACTAGTAGCTCTAGGGT Plc-Clust 
NcoI-Plc CACTCACCATGGGTTAATGCTTTCAGCATATCGT
AGTAAAT 
PlcADITEB 
XbaI-Plc ATCTATCTAGACTATAAAAAAATCAAGCTATATA
TAGG 
PlcADITEB 
NcoI-PlcD CACTCACCATGGTGAATAAACCGCGGAGTAATA
TC 
PlcD / PlcDI 
XbaI-PlcD ATCTATCTAGATTAATCTCCTAACAACCATAAGG
C 
PlcD 
NcoI-PlcI CACTCACCATGGTTGTTAGGAGATTAATTATGAA
GAATTTAG 
PlcI 
XbaI-PlcI ATCTATCTAGATTAATCTGTATGCCGTTTAATTA
GCTGA 
PlcI / PlcDI 
pNZ-F TGTCGATAACGCGAGCATAA  
pNZ-R CAAAGCAACACGTGCTGTAA  
PCR 
fragment 
Description 
Plc-Clust 3,172-bp fragment external to Plc cluster 
PlcADITEB 2,908-bp NcoI/XbaI fragment containing genes plcA, plcD, plcI, plcT, plcE 
and plcB 
PlcD 495-bp NcoI/XbaI fragment containing gene plcD  
PlcI 204-bp NcoI/XbaI fragment containing gene plcI 
PlcDI 662-bp NcoI/XbaI fragment containing genes plcD and plcI 
Plasmid Description 
pNZ8048 Cm
r
; inducible expression vector carrying the nisA promoter (38) 
PNZPlc pNZ8048 derivative containing PlcADITEB 
PNZPlcD pNZ8048 derivative containing PlcD 
PNZPlcI pNZ8048 derivative containing PlcI 
PNZPlcDI pNZ8048 derivative containing PlcDI 
 
607 
a 
Cleavage site for restriction enzymes is underlined in the primers. 608 
 609 
 610 
 611 
 612 
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Figure 1. A) Sequence alignment of all the members of subgroup II circular bacteriocins with plantaricyclin A, using MUSCLE (39). Conserved. 613 
Conservative and semiconservative substitutions are indicated by asterisks, colons, and semicolons, respectively. Bold letters determine the 614 
leader sequence. B) Schematic plantaricyclin A mature peptide. 615 
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 639 
Figure 2. Schematic representation of the gene clusters involved in the production of the circular bacteriocins gassericin A (34), acidocin B (17) 640 
and plantaricyclin A. The known or putative biochemical function or properties are denoted by color, as indicated in the key. 641 
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 660 
 661 
Figure 3. A) Antimicrobial activity of the CFS of Lb. plantarum NI326 and nisin A-induced 662 
L. lactis NZ9000 pNZPlc against A. acidoterrestris sp1. B) Antimicrobial activity of the CFS 663 
of Lb. plantarum NI326 against cultures of L. lactis NZ9000 pNZ8048, L. lactis NZ9000 664 
pNZPlcD, L. lactis NZ9000 pNZPlcI and L. lactis NZ9000 pNZPlcDI un-induced (-) or 665 
induced (+) with nisin A. 666 
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 684 
Figure 4. MALDI TOF Mass spectrometry analysis of the purified plantaricyclin A produced by A) L. lactis pNZPlca; and B) Lb. plantarum 685 
NI326 686 
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